Related Experiment Video

Updated: Jun 9, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

[Avastin treatment in intraocular tumors]

Laura Macovei, Benone Carstocea, Simona Buliga

    Oftalmologia (Bucharest, Romania : 1990)
    |September 11, 2010
    PubMed

    Insights

    Bevacizumab (Avastin) injections into the eyeball show promise for treating intraocular tumors by inhibiting new blood vessel growth. This study evaluates its short-term safety and effectiveness in patients.

    Area of Science:

    • Ophthalmology
    • Oncology
    • Pharmacology

    Background:

    • Bevacizumab, an anti-angiogenic drug, is utilized in cancer treatment by inhibiting tumor vascularization.
    • Intraocular tumors present unique challenges for treatment due to the delicate ocular environment.

    Observation:

    • This study assesses the short-term safety and efficacy of intravitreal bevacizumab (Avastin) for intraocular tumors.
    • Postoperative subjective and objective outcomes were meticulously followed.

    Findings:

    • Bevacizumab effectively inhibits angiogenesis, a key factor in tumor growth.
    • The intravitreal administration of bevacizumab demonstrated favorable short-term safety and effectiveness in managing intraocular tumors.

    Implications:

    • Intravitreal bevacizumab offers a potential therapeutic option for intraocular malignancies.
    • Further research is warranted to explore long-term outcomes and optimal dosing strategies.

    More Related Videos

    Intravitreal Injections in the Ovine Eye03:37

    Intravitreal Injections in the Ovine Eye

    Published on: July 5, 2022

    Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs10:02

    Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

    Published on: July 23, 2016

    Related Concept Videos

    Open Angle Glaucoma: Treatment01:27

    Open Angle Glaucoma: Treatment

    In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
    Drugs such as carbonic anhydrase inhibitors, α2- and...
    Angle Closure Glaucoma: Treatment01:28

    Angle Closure Glaucoma: Treatment

    Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...